Date:
Time:
Location:
Regenerative Medicine
Human mesenchymal stem cells are the cells most often used in regenerative medicine today. They appear in research on joint pain, sports injuries, hair loss and skin aging, and in many clinic websites. This guide explains in plain language what they are, how scientists define them, what an MSC stem cell treatment involves and what the evidence really shows.
Human mesenchymal stem cells are adult cells found in tissues such as umbilical cord, bone marrow and fat. They can develop into bone, cartilage and fat cells in the lab, and they release signals that help regulate inflammation. In medicine they are also called mesenchymal stromal cells, or MSCs.
Because many labs work with these cells, the International Society for Cell & Gene Therapy (ISCT) published minimal criteria in 2006 so that everyone describes the same thing (Dominici et al., Cytotherapy). To be called mesenchymal stromal cells, a population must:
| Criterion | What it means |
|---|---|
| Plastic adherence | The cells stick to the plastic surface of a culture dish. |
| Surface markers | At least 95% carry the markers CD105, CD73 and CD90, and no more than 2% carry blood-cell markers such as CD45 and CD34. |
| Differentiation | In the lab, they can become bone, cartilage and fat cells. |
These criteria help confirm that a product really contains human mesenchymal stem cells and not something else.
Researchers once thought MSCs mainly replaced damaged tissue. Today, most evidence points to a different mechanism: the cells release signals, growth factors and small vesicles that help calm inflammation, regulate the immune response and support the tissue’s own repair. Most injected cells do not survive for long, but their signals can influence the tissue around them.
An MSC stem cell treatment applies human mesenchymal stem cells to a specific area, most often by injection. The main areas studied are:
The evidence is promising but still developing. Several studies report less pain in knee osteoarthritis, while other rigorous reviews found little difference compared with control treatments. Results vary from person to person.
Large reviews of clinical trials have found a favourable safety profile for mesenchymal stem cells therapy. A 2021 analysis of 62 randomized trials found no serious adverse events such as death or infection linked to the cells, although temporary fever was more common (Stem Cell Research & Therapy). Safety depends heavily on the quality of the cells and on medical supervision.
Research has studied MSCs from several tissues, and comparisons between them show mixed results; no single source has been proven best for every use. Umbilical cord tissue is one of the most practical sources, because the cells come from a donated cord and nothing has to be collected from the patient. Whatever the source, these are the quality checks to ask about:
| Quality check | Why it matters |
|---|---|
| Donation with written consent | Confirms ethical origin; umbilical cord tissue is never embryonic |
| Produced by a certified laboratory bank | The bank answers for every batch, with its own licensing and audits |
| Viability and sterility testing | A batch that fails is not shipped and not used |
| Batch recorded in your medical file | Full traceability, with a certificate you can request |
At Rogans, treatment consists of the injection of human mesenchymal stem cells from umbilical cord tissue, produced by a certified laboratory bank, never embryonic. Nothing is collected from your body. Each batch must pass viability and sterility checks before it ships, and it is recorded in your medical file. Learn more about the regenerative medicine program in Bogotá.
Your evaluation is done virtually: a free telemedicine video consultation with a specialist, in English, from wherever you live. If treatment is an option for you, the stem cell injection is done in person in Bogotá, Colombia, applied by a physician in a licensed clinic, with your hotel and transfers arranged.
For an independent overview, read the FDA’s information for patients on regenerative medicine therapies.
No. They are adult cells from tissues such as umbilical cord, and they do not involve embryos.
One MSC product, Ryoncil, was approved in December 2024 for a specific transplant complication in children. No MSC product is approved for joints, pain, hair or skin in the United States.
From umbilical cord tissue, produced by a certified laboratory bank, with a batch certificate you can request.
This article is for general information and does not replace a medical consultation.
Find out whether an MSC stem cell treatment is an option for you. Book a free video consultation.
Searching for the cheapest stem cell therapy in the world is understandable. Insurance rarely pays for regenerative treatment, and prices in the United States can reach tens of thousands of dollars. But the lowest price is not always the best value, and in cell therapy a cheap offer can hide a weak product or missing […]
One of the first questions patients ask is simple: is stem cell therapy covered by insurance? For most people in the United States, the short answer is no, at least for joint, pain and aesthetic treatments. This guide explains why, what Medicare covers, which stem cell procedures insurance does pay for, and how to plan […]
Low back pain is one of the most common reasons adults see a doctor, and for some people it never fully goes away. When physiotherapy, medication and steroid shots stop helping, many start reading about stem cell injections for back pain. This guide explains what they are, which kinds of back pain they are studied […]
Date:
Time:
Location:
You will get the appointment confirmation on WhatsApp at the number ending in to sort out the details and answer any questions
Enter your number and we'll send you a code via SMS and WhatsApp.
Enter the code we sent to via SMS and WhatsApp.
Your number isn't registered yet. Fill in your details to create your account.
Have questions?